Our analysis identified six key immune regulatory genes (TLR2, TLR4, CCR7, IL18, TIRAP and FOXP3) that show differential expression between lung cancer and normal tissues and demonstrate potential prognostic value. The gene discussed is TLR2; the disease is lung cancer.